The role of neoadjuvant FLOT chemotherapy with and without omega 3 in locally advanced gastric carcinoma.
CONCLUSIONS: Omega 3 administrations during chemotherapy in gastric cancer increased the chemotherapy tolerability and decreased the treatment gap between cycles and hence improved gastric cancer resection.
PMID: 33455112 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nutrition | Omega 3 | Statistics | Study | Toxicology